ID JVM-13 AC CVCL_1318 SY JVM 13; JVM13 DR CLO; CLO_0007046 DR CLDB; cl2964 DR CLDB; cl5073 DR ArrayExpress; E-MTAB-7721 DR ArrayExpress; E-MTAB-7722 DR ATCC; CRL-3003 DR BioSample; SAMN01821571 DR BioSample; SAMN01821641 DR BioSample; SAMN03471707 DR DSMZ; ACC-19 DR DSMZCellDive; ACC-19 DR ECACC; 96090516 DR GEO; GSM1266785 DR GEO; GSM1266786 DR Wikidata; Q54899190 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=3262465; RX PubMed=20454443; RX PubMed=24362935; RX PubMed=25315077; RX PubMed=25960936; RX PubMed=28196595; RX PubMed=29666304; RX PubMed=31160637; WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: LL-100 blood cancer cell line panel. CC Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank). CC Part of: MD Anderson Cell Lines Project. CC Doubling time: 58 hours (PubMed=25315077); ~70 hours (DSMZ=ACC-19). CC HLA typing: A*02:01,03:01; B*15:01,56:01; C*01:02,03:03; DQA1*01:03,01:03; DQB1*06:03,06:03; DRB1*13:01,03:38 (PubMed=25960936). CC HLA typing: A*02:01:01,03:01:01; B*15:01:01,56:01:01; C*01:02:01,03:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,06:01; DQA1*01:03:01,01:03:01; DQB1*06:03:01,06:03:01; DRA*01:02:02,01:02:02; DRB1*13:01:01,13:01:01 (DSMZCellDive=ACC-19). CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. ST Source(s): ATCC=CRL-3003; DSMZ=ACC-19; ECACC=96090516 ST Amelogenin: X,Y ST CSF1PO: 10,12 ST D13S317: 9,11 ST D16S539: 11 ST D18S51: 14,19 ST D19S433: 14 ST D21S11: 29 ST D2S1338: 18,20 ST D3S1358: 15,19 ST D5S818: 11 ST D7S820: 9 ST D8S1179: 13,13.2 ST FGA: 22,24 ST Penta D: 10 ST Penta E: 9,10 ST TH01: 6,7 ST TPOX: 10,11 ST vWA: 16,18 DI NCIt; C4337; Mantle cell lymphoma DI ORDO; Orphanet_52416; Mantle cell lymphoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 60-69Y CA Transformed cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 26 // RX PubMed=25315077; DOI=10.3109/10428194.2014.970548; RA Fogli, Laura K. RA Williams, Michael E. RA Connors, Joseph M. RA Reid, Yvonne A. RA Brown, Kathleen RA O'Connor, Owen A. RT "Development and characterization of a Mantle Cell Lymphoma Cell Bank RT in the American Type Culture Collection."; RL Leuk. Lymphoma 56:2114-2122(2015). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, A. Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=24362935; DOI=10.1038/nm.3435; RA Rahal, Rami RA Frick, Mareike RA Romero, Rodrigo RA Korn, Joshua M. RA Kridel, Robert RA Chan, Fong Chun RA Meissner, Barbara RA Bhang, Hyo-eun Carrie RA Ruddy, David A. RA Kauffmann, Audrey RA Farsidjani, Ali RA Derti, Adnan RA Rakiec, Daniel RA Naylor, Tara RA Pfister, Estelle RA Kovats, Steve RA Kim, Sunkyu RA Dietze, Kerstin RA Dorken, Bernd RA Steidl, Christian RA Tzankov, Alexandar RA Hummel, Michael RA Monahan, John E. RA Morrissey, Michael P. RA Fritsch, Christine RA Sellers, William Raj RA Cooke, Vesselina G. RA Gascoyne, Randy D. RA Lenz, Georg RA Stegmeier, Frank RT "Pharmacological and genomic profiling identifies NF-kappaB-targeted RT treatment strategies for mantle cell lymphoma."; RL Nat. Med. 20:87-92(2014). // RX PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981; RA Boegel, Sebastian RA Lower, Martin RA Bukur, Thomas RA Sahin, Ugur RA Castle, John C. RT "A catalog of HLA type, HLA expression, and neo-epitope candidates in RT human cancer cell lines."; RL OncoImmunology 3:e954893.1-e954893.12(2014). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=3262465; PMCID=PMC1541467; RA Vaz de Melo, Junia RA Foroni, Letizia RA Brito-Babapulle, Vasantha RA Luzzatto, Lucio RA Catovsky, Daniel RT "The establishment of cell lines from chronic B cell leukaemias: RT evidence of leukaemic origin by karyotypic abnormalities and Ig gene RT rearrangement."; RL Clin. Exp. Immunol. 73:23-28(1988). // RX PubMed=29666304; DOI=10.1158/1078-0432.CCR-17-3004; RA Pham, Lan V. RA Huang, Sheng-Jian RA Zhang, Hui RA Zhang, Jun RA Bell, Taylor RA Zhou, Shou-Hao RA Pogue, Elizabeth RA Ding, Zhi-Yong RA Lam, Laura RA Westin, Jason RA Davis, R. Eric RA Young, Ken H. RA Medeiros, L. Jeffrey RA Ford, Richard Joseph Jr. RA Nomie, Krystle RA Zhang, Leo RA Wang, Michael RT "Strategic therapeutic targeting to overcome venetoclax resistance in RT aggressive B-cell lymphomas."; RL Clin. Cancer Res. 24:3967-3980(2018). // RX PubMed=20454443; DOI=10.1155/2010/904767; PMCID=PMC2861168; RA Uphoff, Cord C. RA Denkmann, Sabine A. RA Steube, Klaus G. RA Drexler, Hans Gunther RT "Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human RT and other primate cell lines."; RL J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010). // RX PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646; RA Quentmeier, Hilmar RA Pommerenke, Claudia RA Dirks, Wilhelm Gerhard RA Eberth, Sonja RA Koeppel, Max RA MacLeod, Roderick A.F. RA Nagel, Stefan RA Steube, Klaus G. RA Uphoff, Cord C. RA Drexler, Hans Gunther RT "The LL-100 panel: 100 cell lines for blood cancer studies."; RL Sci. Rep. 9:8218.1-8218.14(2019). //